Johnson & Johnson (Switzerland)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Johnson & Johnson (United States)美国4
2. Hospital Universitario de La Princesa西班牙1
3. Universitat Autònoma de Barcelona西班牙1
4. Janssen (Netherlands)荷兰1
5. Merck & Co., Inc., Rahway, NJ, USA (United States)美国1
6. Johnson & Johnson (Netherlands)荷兰1
7. Syneos Health (United States)美国1
8. RTI Health Solutions美国1

按月发文

逐年被引

最新文献

1. 1
   Active Safety Surveillance Using Real‐World Evidence (ASSURE) Implementation: Transparent and Reproducible Real‐World Evidence Standardized Framework to Support Safety Signal EvaluationPharmacoepidemiology and Drug Safety20260
2. 2
   Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post‐Authorisation Safety Study Using the Spanish ENEIDA RegistryPharmacoepidemiology and Drug Safety20251
3. 3
   Quantitative Benefit–Risk Assessment of Vaccination Against COVID ‐19: A Systematic ReviewPharmacoepidemiology and Drug Safety20250
4. 4
   Increase transparency and reproducibility of real‐world evidence in rare diseases through disease‐specific Federated Data NetworksPharmacoepidemiology and Drug Safety202410
5. 5
   Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision makingPharmacoepidemiology and Drug Safety202316

高被引文献

1. 1
   Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision makingPharmacoepidemiology and Drug Safety202316
2. 2
   Increase transparency and reproducibility of real‐world evidence in rare diseases through disease‐specific Federated Data NetworksPharmacoepidemiology and Drug Safety202410
3. 3
   Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post‐Authorisation Safety Study Using the Spanish ENEIDA RegistryPharmacoepidemiology and Drug Safety20251

主要发表期刊